Invesco’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.2M | Buy |
1,559,378
+274,960
| +21% | +$9.91M | 0.01% | 1017 |
|
|
2025
Q1 | $40M | Buy |
1,284,418
+326,525
| +34% | +$10.2M | 0.01% | 1126 |
|
|
2024
Q4 | $24.4M | Buy |
957,893
+238,508
| +33% | +$6.08M | ﹤0.01% | 1388 |
|
|
2024
Q3 | $20.4M | Sell |
719,385
-1,017,136
| -59% | -$28.8M | ﹤0.01% | 1455 |
|
|
2024
Q2 | $45.8M | Buy |
1,736,521
+1,062,833
| +158% | +$28M | 0.01% | 1048 |
|
|
2024
Q1 | $20.5M | Buy |
673,688
+16,833
| +3% | +$511K | ﹤0.01% | 1441 |
|
|
2023
Q4 | $18.5M | Buy |
656,855
+46,849
| +8% | +$1.32M | ﹤0.01% | 1453 |
|
|
2023
Q3 | $16.6M | Sell |
610,006
-79,942
| -12% | -$2.17M | ﹤0.01% | 1442 |
|
|
2023
Q2 | $21.2M | Sell |
689,948
-23,219
| -3% | -$714K | 0.01% | 1338 |
|
|
2023
Q1 | $25.7M | Sell |
713,167
-2,169,823
| -75% | -$78.2M | 0.01% | 1226 |
|
|
2022
Q4 | $114M | Sell |
2,882,990
-247,861
| -8% | -$9.8M | 0.03% | 671 |
|
|
2022
Q3 | $126M | Buy |
3,130,851
+479,358
| +18% | +$19.3M | 0.04% | 582 |
|
|
2022
Q2 | $111M | Buy |
2,651,493
+1,968,126
| +288% | +$82.7M | 0.03% | 650 |
|
|
2022
Q1 | $26.6M | Buy |
683,367
+139,768
| +26% | +$5.45M | 0.01% | 1318 |
|
|
2021
Q4 | $21.7M | Sell |
543,599
-84,611
| -13% | -$3.37M | 0.01% | 1499 |
|
|
2021
Q3 | $22.7M | Sell |
628,210
-65,308
| -9% | -$2.36M | 0.01% | 1485 |
|
|
2021
Q2 | $28.4M | Buy |
693,518
+30,885
| +5% | +$1.27M | 0.01% | 1388 |
|
|
2021
Q1 | $28.9M | Buy |
662,633
+451,898
| +214% | +$19.7M | 0.01% | 1322 |
|
|
2020
Q4 | $10.5M | Sell |
210,735
-621,386
| -75% | -$31.1M | ﹤0.01% | 1774 |
|
|
2020
Q3 | $35M | Buy |
832,121
+82,121
| +11% | +$3.45M | 0.01% | 1059 |
|
|
2020
Q2 | $36.4M | Buy |
+750,000
| New | +$36.4M | 0.01% | 1042 |
|